Factor products in the treatment of hemophilia.
Miller
Kim L
KL
Center for Cancer and Blood Disorders, Children's Medical Center, Dallas, Texas, USA.
D016903:Drug Monitoring / Q000379:methods; D005164:Factor IX / Q000600:supply & distribution / Q000627:therapeutic use*; D005169:Factor VIII / Q000600:supply & distribution / Q000627:therapeutic use*; D006467:Hemophilia A / Q000097:blood / Q000150:complications / Q000628:therapy*; D006801:Humans; D009722:Nurse Practitioners; D024802:Nurse's Role; D010353:Patient Education as Topic; D018579:Patient Selection; D010371:Pediatric Nursing / Q000379:methods; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000379:methods; D013997:Time Factors
D005169:Factor VIII; D005164:Factor IX